• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>PSA

PSA

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Elior Group: Results

    Elior Group: Results

  2. Wage Hope at PurpleStride San Francisco, the Walk to End Pancreatic Cancer

    Wage Hope at PurpleStride San Francisco, the Walk to End Pancreatic Cancer

  3. Public Storage Announces Pricing of 5.15% Cumulative Preferred Shares of Beneficial Interest, Series F

    Public Storage Announces Pricing of 5.15% Cumulative Preferred Shares of Beneficial Interest, Series F

  4. Long Beach’s McBride High School Team to Beat as Three-Day Solar Cup™ Kicks off at Lake Skinner

    Long Beach’s McBride High School Team to Beat as Three-Day Solar Cup™ Kicks off at Lake Skinner

  5. Wellbeing Beauty Brand, Philosophy and Its Hope & Grace Initiative, Kick off Mental Health Month with “How Are You, Really?” PSA and National Campaign

    Wellbeing Beauty Brand, Philosophy and Its Hope & Grace Initiative, Kick off Mental Health Month with “How Are You, Really?” PSA and National Campaign

  6. Blue Earth Diagnostics’ FALCON Trial of Fluciclovine (18F) PET/CT Imaging in Recurrent Prostate Cancer Stops Recruitment after Successful Interim Analysis

    Blue Earth Diagnostics’ FALCON Trial of Fluciclovine (18F) PET/CT Imaging in Recurrent Prostate Cancer Stops Recruitment after Successful Interim Analysis

  7. PurpleStride Washington D.C. Aims to Change the Course of Nation’s Toughest Cancer

    PurpleStride Washington D.C. Aims to Change the Course of Nation’s Toughest Cancer

  8. Xenetic Biosciences to Host 2017 First Quarter Update Conference Call

    Xenetic Biosciences to Host 2017 First Quarter Update Conference Call

  9. Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac

    Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac

  10. Razberi CEO to Discuss Cybersecurity Best Practices at TEC 2017

    Razberi CEO to Discuss Cybersecurity Best Practices at TEC 2017

12

©2017 Morningstar Advisor. All right reserved.